Company intelligence / Profile preview

StimMed

Ownership: Private
Development stage: Other

Overview

StimMed has developed and commercialized the FDA-approved StimSox™ System, a portable neuromuscular electrical stimulation device designed to prevent venous thrombosis and temporarily increase local blood circulation in healthy leg muscles. The product is clinically proven and used for immediate post-surgical care to reduce the risk of DVT and PE.

Therapeutic areas: Cardiovascular
Modalities: DeviceNeuromuscular electrical stimulation device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on StimMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StimMed.

Explore the full profile